Donor-derived Cell-free DNA Combined With Histology Improves Prediction of Estimated Glomerular Filtration Rate Over Time in Kidney Transplant Recipients Compared With Histology Alone. Issue 8 (August 2020)

• Record Type: Journal Article
• Authors: Huang, Edmund; Gillespie, Matthew; Ammerman, Noriko; Vo, Ashley; Lim, Kathlyn; Peng, Alice; Najjar, Reiad; Sethi, Supreet; Jordan, Stanley C.; Mirocha, James; Haas, Mark
• Is Part Of: Transplantation direct. Volume 6:Issue 8(2020)
• Publication Date: 2020-08
• Subjects: Transplantation of organs, tissues, etc -- Periodicals; Transplantation -- Periodicals; 362.19795
• DOI: 10.1097/TXD.0000000000001027
• Languages: English
• ISSNs: 2373-8731

Abstract

Abstract : Background: Higher Banff inflammation and chronicity scores on kidney transplant biopsies are associated with poorer graft survival, although histology alone has limitations in predicting outcomes. We investigated if integrating donor-derived cell-free DNA (dd-cfDNA, Allosure; CareDx, Inc.) with Banff biopsy scores into a predictive model for estimated glomerular filtration rate over time can improve prognostic assessment versus histology alone. Methods: We identified 180 kidney transplant patients with dd-cfDNA assessed within 1 mo of biopsy. Using linear mixed–effects models, a prediction model of Banff histology scores and dd-cfDNA on estimated glomerular filtration rate over time was derived. Nested models were compared using the likelihood-ratio test, Akaike Information Criterion, and Bayesian Information Criterion to assess if inclusion of dd-cfDNA into a model consisting of Banff biopsy scores would improve model fit. Results: Univariate models identified significant covariate-by-time interactions for cg = 3 versus <3 (coefficient: −1.3 mL/min/1.73 m 2 /mo; 95% confidence interval [CI], −2.4 to −0.2; P = 0.02) and ci + ct ≥ 3 versus <3 (coefficient: −0.7 mL/min/1.73 m 2 /mo; 95% CI, −1.3 to −0.1; P = 0.03) and a trend toward significant covariate-by-time interaction for dd-cfDNA (coefficient: −0.5 mL/min/1.73 m 2 /mo; 95% CI, −1.0 to 0.1; P = 0.08). Addition of acute inflammation (i, t, and v), microvascular inflammation (g and ptc), and inflammation in area of interstitial fibrosis and tubular atrophy scores to chronicity scores (cg ≥ 3 and ci + ct ≥ 3) did not improve model fit. However, a model including dd-cfDNA with cg and ci + ct with covariate-by-time interactions had a better model fit compared with cg and ci + ct alone (likelihood-ratio test statistic = 21.1; df = 2; P < 0.001). Conclusions: Addition of dd-cfDNA to Banff biopsy scores provided better prognostic assessment over biopsy characteristics alone. Abstract : Supplemental Digital Content is available in the text.